Synthesis and biological evaluation of a novel series of furans: Ligands selective for estrogen receptor α

Journal of Medicinal Chemistry

Volumn 44, Issue 23, 2001, Pages 3838-3848

  Mortensen, D S ^a   Rodriguez, A L ^a   Carlson, K E ^a   Sun, J ^b   Katzenellenbogen, B S ^b   Katzenellenbogen, J A ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4,5 TRIS(4 HYDROXYPHENYL)FURAN DERIVATIVE; ESTROGEN RECEPTOR ALPHA; FURAN DERIVATIVE; PYRROLE DERIVATIVE; RECEPTOR SUBTYPE; THIOPHENE DERIVATIVE; UNCLASSIFIED DRUG;

ALKYLATION; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG BINDING; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; LAMB; NONHUMAN; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION;

ANIMALS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; FURANS; HUMANS; LIGANDS; MODELS, MOLECULAR; PHENOLS; PYRROLES; RADIOLIGAND ASSAY; RECEPTORS, ESTROGEN; SHEEP; STRUCTURE-ACTIVITY RELATIONSHIP; THIOPHENES; TRANS-ACTIVATION (GENETICS); TRANSFECTION; TUMOR CELLS, CULTURED; UTERUS;

EID: 0035829426     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm010211u     Document Type: Article

References (47)

1. Modifiers of estrogen action
2. Estrogen replacement therapy and fractures in older women
3. Hormone-replacement therapy - Breast versus heart versus bone
4. Designer estrogens
5. Estrogen and coronary heart disease in women
6. Postmenopausal estrogen therapy and cardiovascular disease - Ten year follow-up from the nurses' health stud
7. Hormonal regulation of lipoprotein(a) levels: Effects of estrogen replacement therapy on lipoprotein(a) and actute phase reactants in postmenopausal women
8. Estrogen effects on cognition in menopausal women
9. Estrogen replacement therapy and cognitive function in postmenopausal women without dementia
10. Cloning of a novel receptor expressed in rat prostate and ovary
11. ERβ: Identification and charaterization of a novel human estrogen receptor
12. Comparison of the ligand binding specificity and transcipt tissue distribution of estrogen receptors α and β
13. Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists
14. Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors α and β
15. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites
16. Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-α or estrogen receptor-β
17. Acyclic amides as estrogen receptor ligands: Synthesis, binding, activity, and receptor interaction
18. Estrogen receptor subtype-selective ligands: Asymmetric synthesis and biological evaluation of cisand trans-5, 11-dialkyl-5,6,11,12-tetrahydrochrysenes
19. Structure of the ligand-binding domian of oestrogen receptor beta in the presence of a partial agonist and a full antagonist
20. Novel structural templates for estrogenreceptor ligands and prospects for combinatorial synthesis of estrogens
21. Development of combinatorial approaches towards selective estrogen receptor modulators: Investigations of acyclic amides and tetra-substituted pyazoles
22. Estrogen pyrazoles: Defining the pyrazole core structure and the orientation of substituents in the ligand binding pocket of the estrogen receptor
23. Solid-phase synthesis of tetrasubstituted pyrazoles, novel ligands for the estrogen receptor
24. Pyrazole ligands: Structure-affinity/activity relationships of estrogen receptor-α selective agonists
25. Triarlpyrazoles with basic side chains: Development of pyrazole-based estrogen receptor antagonists
26. Structure-activity relationship of antiestrogens: A study using triarylbutenone, benzofuran, and triarylfuran analogues as a model for triarylethylenes and triarypropenones
27. Synthesis and biological activity of 2,3- and 3,4-diarylfurans and 2,3,4triaryl-2,5-dihydrofurans
28. Antifertility agent: Part ix-synthesis of 2,3,4-triphenylfurans & 2,3,4-triphenyl-5-methylfurans
29. Studies in potential antifertility agents: Part VII - synthesis of dialkylaminoethyl derivatives of 2,4,5-triphenylpyrroles & 2,4,5-triphenylfurans
30. Catalyzed addition of aldehydes to activated double bonds-a new synthetic approach
31. Synthesis and application of small molecule libraries
32. Reaction of 2,4-Bis(4-methoxyphenyl)-1,3,2,4-dithiadiphosphetane-2,4-disulphide with substituted butane-1,4-diones: Part II - Novel synthesis of substituted thiophenes & furans
33. Rearrangements and transalkylation of t-butylthiophenes
34. The synthesis of 25-diarylthiophenes
35. A convenient route to polythiophenes
36. Preparation d'heterocycles encombres: Di-tert-butyl-2,5-furanne, pyrrole et thiophene
37. Photoaffinity labels for estrogen binding proteins of rat uterus
38. Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: Evidence that an open pocket conformation is required for ligand interaction
39. The estradiol pharmacophore: Ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site
40. Comparative QSAR analysis of estrogen receptor ligands
41. 2-Arylindenes and 2-arylindenones: Molecular structures and considerations in the binding orientation of unsymmetrical nonsteroidal ligands to the estrogen receptor
42. Furans with basic side chains: Synthesis and biological evaluation of a novel series of antagonists with selectivity for the estrogen receptor alpha
43. Molecular basis of agonism and antagonism in the oestrogen receptor
44. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
45. Analysis of estrogen receptor transcriptional enhancement bya a nuclear hormone receptor coactivator